A Prospective, Randomized, Open-label Clinical Trial to Assess Fever Following Simultaneous Versus Sequential Administration of PCV13, DTaP Vaccine and IIV in Young Children
Latest Information Update: 20 Nov 2024
At a glance
- Drugs DTaP vaccine (Primary) ; Influenza virus vaccine (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Diphtheria; Influenza virus infections; Pertussis; Pneumococcal infections; Tetanus
- Focus Adverse reactions
Most Recent Events
- 11 Feb 2020 New trial record
- 06 Feb 2020 Results published in the Pediatrics